Perioperative Treatment of Resectable Liver Metastases
Status:
Withdrawn
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
This randomized, controlled, multicenter, non-comparative phase II trial compares an
intensified perioperative treatment of patients with resectable synchronous or metachronous
colorectal liver metastases to primary surgery and adjuvant systemic chemotherapy.